Dexcom Highlights CGM Advances and Product Roadmap at ATTD 2026
During the conference, Dexcom showcased upcoming device updates, new platform features, and future innovations designed to expand and enhance its CGM ecosystem.
Promising Results for Omnipod’s Type 2 Fully Closed-Loop Algorithm
Results from the EVOLUTION 2 trial presented at ATTD showed 68% time in range using a fully closed-loop system—with no mealtime boluses and minimal time below range.
Essential On-the-Go Diabetes Supplies: Coolers, Travel Bags & More
Here's a list of our go-to accessories from coolers, cases, and patches, to snacks that help keep your diabetes management on track no matter where you go.
SynchNeuro's CGM Could Measure Glucose Levels Using Brainwaves
A new behind-the-ear EEG sensor aimed at the pre-diabetes and type 2 diabetes community is being designed to read blood glucose levels directly from brain activity.
FDA Moves Forward With Review Of Inhaled Insulin For Children
The FDA has accepted MannKind’s application to expand the use of its inhaled insulin, Afrezza, to children, marking a key step toward potential pediatric approval.
T1Ds Are Using GLP-1s: The Latest Research & The Road To Coverage
Medications like Ozempic, Wegovy, and Mounjaro are showing promising results for people with type 1 diabetes — but they’re still not approved for this use.
Diagnosed With Type 1.5 Diabetes — A LADA Diagnosis Story
Many adults diagnosed later in life may actually have LADA or type 1.5 diabetes — here’s how it works, how it differs, and a story navigating diagnosis.
